Clinical Trials Directory

Trials / Unknown

UnknownNCT06552650

Evaluating the Effectiveness of an Early Exercise Program After Breast Reconstruction

Randomized Controlled Study to Evaluate the Effect of Early Exercise on Functional Restoration of Exercise and Surgical Outcomes After Breast Reconstruction

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
72 (estimated)
Sponsor
Yonsei University · Academic / Other
Sex
Female
Age
19 Years – 70 Years
Healthy volunteers
Accepted

Summary

Breast reconstruction is an important step and option after mastectomy and can help improve the quality of life of breast cancer patients. Therefore, the proportion of patients undergoing breast reconstruction in conjunction with mastectomy is steadily increasing. Despite recent advances in less invasive techniques, postoperative movement restrictions are unavoidable, and these postoperative pain or functional limitations can last for months to years. Patients most often experience a decrease in shoulder function, which negatively impacts their physical function and is an important factor in their ability to perform activities of daily living. Early postoperative exercise has been proven to have positive results in promoting the recovery of shoulder function in breast cancer patient. However, there is a lack of research on the effectiveness of early postoperative exercise in the context of breast reconstruction. Therefore, this study aims to evaluate the effect of early postoperative exercise on patients' shoulder and trunk function after breast reconstruction.

Conditions

Interventions

TypeNameDescription
BEHAVIORALExerciseFour supervised exercise interventions after surgery: One exercise education session per week from postoperative day 5 through 1 month Subsequent home-based exercise: Home-based exercise recommendations from 1 month to 3 months post-surgery
OTHERUsual CareThe full spectrum of patient care practices in which clinicians have the opportunity (which is not necessarily seized) to individualize care

Timeline

Start date
2023-11-20
Primary completion
2023-11-20
Completion
2025-06-30
First posted
2024-08-14
Last updated
2024-08-14

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT06552650. Inclusion in this directory is not an endorsement.